Applied DNA Sciences, Inc.
APDN
$3.00
-$0.26-7.98%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -69.05% | -17.82% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -69.05% | -17.82% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -- | -- | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -10.05% | 6.84% | |||
| Operating Income | -6.71% | -16.79% | |||
| Income Before Tax | -- | -- | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -- | -- | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -19.41% | -25.19% | |||
| EBIT | -6.71% | -16.79% | |||
| EBITDA | -8.15% | -15.07% | |||
| EPS Basic | 108.77% | 44.84% | |||
| Normalized Basic EPS | -- | -- | |||
| EPS Diluted | 108.77% | 44.84% | |||
| Normalized Diluted EPS | -- | -- | |||
| Average Basic Shares Outstanding | 541.26% | 112.38% | |||
| Average Diluted Shares Outstanding | 541.26% | 112.38% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||